MedTrace Logo

Physical Performance and 3D Shoulder Kinematics of Asymptomatic Unilateral/Bilateral Overhead Athletes and Non-athletes

NCT02852707 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2021-01-06

No results posted yet for this study

Summary

This study compares the performance and 3-dimensional shoulder kinematics between sides in unilateral overhead-throwers (volleyball attackers), bilateral overhead athletes (swimmers) and non-athletes during two physical performance measures of the upper extremity, one in an open kinetic chain position (unilateral seated shot put test) and the other in a closed kinetic chain position (upper quarter Y balance test)

Conditions

  • Shoulder Pain

Interventions

BEHAVIORAL

Chronic exposure to unilateral overhead sports activity

Overhead sports athletes that have been chronically exposed (≥ 2 years) predominantly to specific unilateral overhead movement patterns of the dominant extremity ("throwing arm"), such as throwing or hitting a ball ("asymmetrical overhead sports).

BEHAVIORAL

Chronic exposure to bilateral overhead sports activity

Overhead sports athletes that have been chronically exposed (≥ 2 years) predominantly to bilateral overhead movement patterns of the upper extremities, such as swimmers ("symmetrical overhead sports").

BEHAVIORAL

Not exposed

People not engaged in regular sports competition/exercise training.

Sponsors & Collaborators

  • University of Lisbon

    collaborator OTHER

  • Instituto Politécnico de Leiria

    collaborator OTHER

  • Universidade do Porto

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2021-04-30
Completion
2021-07-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02852707 on ClinicalTrials.gov